Posted by AGORACOM-JC
at 8:08 AM on Monday, February 8th, 2021
Agreement a Result of Sales and Marketing Efforts Made by TELUS (T:TSX; TU: NYSE) Through its IoT Marketplace
Company has been selected by Big White Ski Resort to deploy its venue management platform for the purposes of providing its visitors and staff with complementary COVID-19 safety protocols through its venue management platform while also creating significant revenue opportunities for both parties.
Potential to generate $7.2M – $9.6M over term of agreement
VANCOUVER, British Columbia., Feb. 08, 2021 — Loop Insights Inc. (MTRX:TSXV) (RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated venue tracing to the brick and mortar space, is pleased to announce the Company has been selected by Big White Ski Resort (“ Big White Ski Resort ”) to deploy its venue management platform for the purposes of providing its visitors and staff with complementary COVID-19 safety protocols through its venue management platform while also creating significant revenue opportunities for both parties.
BIG WHITE SKI RESORT SELECTS LOOP, IN PARTNERSHIP WITH TELUS, TO PROVIDE VENUE MANAGEMENT PLATFORM TO ESTABLISH INFRASTRUCTURE TO PROTECT STAFF AND GUESTS
In support of Big White Ski Resort and British Columbia’s tourism industry, Loop Insights will deploy its venue tracing solution across Big White Ski Resort and its facilities, aiding the resort to continue to ensure the safety of its staff and customers.
Having recognized the importance of accurate venue tracing protocols in the fight against COVID-19, Loop will work with Big White Ski Resort to maintain the safety of all guests and staff using the Loop venue management platform. The ultimate goal of the deployment is to provide an enhanced customer experience through guest and staff check-ins and to continue to mitigate the spread of COVID-19.
Loop’s venue tracing technology is based on a science and data-driven approach to provide businesses with complementary safety protocols. Through this latest deployment, Loop is working with Big White Ski Resort to ensure the appropriate infrastructure is in place to continue to mitigate the spread of COVID-19 through real-time alerts and automated safety updates sent via the platform.
Michael J Ballingall Senior Vice President of Big White Ski Resort stated: “After being introduced to Loop Insights’ venue management platform through our partnership with TELUS and its IoT Marketplace, Big White Ski Resort recognized its ability to provide us with the peace of mind necessary to deliver the best ski resort experience possible. Also, we are excited about the opportunities by leveraging Loop’s platform to create new revenue streams through unique marketing opportunities.”
VENUE MANAGEMENT REVENUE MODEL HAS POTENTIAL TO GENERATE $7,200,000 – $9,600,000 OVER TERM OF AGREEMENT FOR LOOP AND BIG WHITE SKI RESORT
Tags: AI, Amazon, artificial intelligence, Big data, Bitcoin, covid19, Covid19 tracing, crypto, CSE, Ethereum Posted in All Recent Posts, Loop Insights Inc. | Comments Off on Loop Insights $MTRX $RACMF Signs Four-Year Venue Management Agreement Through #TELUS $T.ca #IoT Marketplace with Big White Ski Resort, One Of Canada’s Top 5 Ski Resorts, with Potential to Generate $7.2 – $9.6 Million in Newline Revenue For Loop and Big White Ski Resort $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca
Posted by AGORACOM-JC
at 4:20 PM on Thursday, February 4th, 2021
California is one of the largest cannabis markets in the world and Harborside has more than a decade of market success, making it one of the oldest and most respected retailers in California, commanding a 3% share of the entire market.
Awarded one of the first six medical cannabis licenses in the USA
Operations have generated over $400M in cumulative sales since inception
For the full year ended 2020, the Company is expecting:
Gross revenues in line with previously issued guidance of approximately $61 – 63 million, and positive EBITDA
Standalone gross revenues of between $68 – $72 million full year ended 2021
Expects a 2021 full year of Adjusted EBITDA in the range of 15 – 17% of revenues
Sit back, relax and watch this powerful interview.
Posted by AGORACOM
at 9:59 AM on Thursday, February 4th, 2021
Hydreight is a U.S.-based mobile health and wellness service provider
The firm leverages decentralized healthcare to bring quality telehealth to the masses in an efficient, scalable and cost effective way
The acquisition is expected to close tomorrow
Victory Square Technologies Inc. (“Victory Square” or the “Company”) (CSE:VST) (OTC:VSQTF) (FWB:6F6), a company that provides investors access to a diverse portfolio of next generation companies in key sectors including: digital health, gaming, blockchain, AR/VR, cybersecurity, and cloud computing, is pleased to announce that it has executed a binding share purchase agreement (the “SPA”) dated January 29, 2021 with the shareholders of IV Hydreight Inc. (“Hydreight”), a mobile health and wellness service provider operating in the United States, pursuant to a share purchase agreement to acquire all of the shares of Hydreight (the “Acquisition”). Closing of the Acquisition is expected to occur on or about February 5, 2021.
Founded in 2018, Hydreight provides a unique, custom built, proprietary telemedicine service that allows users to book confidential health & wellness and/or medical services at their home, hotel, office or wherever they may need discreet assistance.
The business model of Hydreight leverages decentralized healthcare to bring quality telehealth, medical, health and wellness services to the masses in an efficient, scalable and cost effective way.
Hydreight Highlights
Hydreight provides a completely compliant turnkey business model for health professionals to offer fully licensed medical, health & wellness services through an on-demand and on-site platform.
Hydreight’s proprietary technology, mobile compliant medical inventory and integrated HIPPA compliant management tools make it the gold standard for USA state-certified mobile medicine protocols.
In addition to providing telehealth services, Hydreight also provides a diverse suite of health & wellness protocols that include IV drip, Botox, COVID-19 testing, and other medical and medispa treatments.
Posted by AGORACOM
at 2:14 PM on Wednesday, February 3rd, 2021
John published a new chart showing the stock pricing for the Treaty companies compared to the value of Treaty Creek that each company owns.
In American Creek’s case it is trading at a 74% discount to its contractual value of “20% of Treaty Creek
John Newell is a portfolio manager at Fieldhouse Capital Management and president and CEO of Golden Sky Minerals Corp. He has 38 years of experience in the investment industry acting as an officer, director, portfolio manager and investment advisor with some of the largest investment firms in Canada including Scotia McLeod, CIBC Wood Gundy and Richardson Greenshields (RBC Capital Markets). Newell is a specialist in precious metal equities and related commodities, and follows a disciplined proprietary approach incorporating equity research, analytical frameworks and risk controls to evaluate and select long and short stocks primarily from the Canadian small and mid-cap coverage. Many large, midcap and junior precious metal companies use his technical charts. Newell is a registered portfolio manager in Canada (advising representative).
On Monday February 1st, 2021 John published a new chart showing the stock pricing for the Treaty companies compared to the value of Treaty Creek that each company owns. In American Creek’s case it is trading at a 74% discount to its contractual value of “20% of Treaty Creek”.
Below are Johns notes and charts:
Déjà vu all over againAMK owns a 20% carried interest in the Treaty Creek Gold Project located in BC’s Golden Triangle. Tudor (TUD) owns 60%, Teuton (TUO) 20%, and American Creek (AMK) 20%. As Highlighted in the spread sheet below.AMK is trading at a 74% discount to Tudor (at $2.50 per share). This represents the same deep undervaluation compared to Tudor as when AMK was trading under $0.10 per share.Recently completed 45,600 meter highly successful drill program to expand and extend gold mineralization at Treaty Creek. The deposit remains open in all directions.Maiden resource is being calculated and will be announced soon.Tudor’s technical chart breaking the short-term downtrend line after last years big run.AMK has exchange, regulatory, and shareholder approval for their “Stinger” spin-out to add shareholder value, giving shareholders a cash rich past producer next to Ascot Resources.Strong insiders share ownership of AMK shares, aligning with shareholders
Posted by AGORACOM-JC
at 2:10 PM on Wednesday, February 3rd, 2021
Proceeds of the Convertible Loan are to be used exclusively for capital expenditures at the Company’s Daly Facility located in Modesto, California
Loan to Increase Production Capacity by 400% & Shift Company into a Cashflow Positive Status Once Daly Facility Opened
Vancouver, British Columbia–(February 3, 2021) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company“) is pleased to announce that it has entered into a binding term sheet (the “Term Sheet“) with Wild Horse Properties L.P. (the “Lender” or “Wild Horse“) for a secured convertible loan (the “Convertible Loan“) in the aggregate principal amount of US$2 million (the “Principal Amount.“).
The proceeds of the Convertible Loan are to be used exclusively for capital expenditures at the Company’s Daly Facility located in Modesto, California (the “Facility.“).
“We are excited to finally unlock the production capacity of the Daly Facility with this direct investment. We believe that scaling our cultivation capacity precipitates industrial level distribution, manufacturing and processing rewarding shareholders with significant revenue growth. We have been in the planning stage for several months,” stated Alan Applonie, Company General Manager, “and are very happy to have secured the necessary funding required to realize this vision.” A reminder to shareholders, Mr. Applonie comes from Taylor Farms an organic produce grower in the central valley where Alan was part of the original founding management team and responsible for annual gross revenues exceeding US$1 Billion.
The Facility build out consists of four phases; with receipt of the Company’s occupancy permit for Phase One, the Company will be shifting its distribution business from the Jerusalem property. Cultivation will continue at full capacity at the Jerusalem facility.
Posted by AGORACOM
at 1:08 PM on Wednesday, February 3rd, 2021
1st tranche of $4M
Insiders Participating
Expected to Close Further $1M
Loncor Resources Inc. (“Loncor” or the “Company“) (TSX: “LN”; OTCQX: “LONCF”; FSE: “LO51”) is pleased to announce that, further to its January 22, 2021 press release, it has closed a first tranche of its non-brokered private placement financing (the “Financing“) for 8,000,000 units of the Company (the “Units”) at a price of Cdn$0.50 per Unit for gross proceeds of Cdn$4,000,000. Each Unit consists of one common share of the Company and one-half of one common share purchase warrant (each whole common share purchase warrant, a “Warrant“) of the Company, with each Warrant entitling the holder thereof to acquire one common share of the Company at an exercise price of Cdn$0.75 for a period of 12 months following the closing date of the Financing. A total of 1,400,000 of the Units were purchased by insiders of the Company. The Company expects to close the balance of the Financing (up to 2,000,000 Units at a price of Cdn$0.50 per Unit for gross proceeds of up to Cdn$1,000,000) next week.
The Company intends to use the proceeds from the Financing for continued exploration and development of the Company’s Imbo Project (including finalizing the current drill program at the Adumbi gold deposit and, following this program, undertaking a Preliminary Economic Assessment of Adumbi and its neighbouring deposits) and for general corporate purposes.
Posted by AGORACOM
at 9:57 AM on Wednesday, February 3rd, 2021
Doubles the size of the bought deal to $10 million
Red Light Holland Corp. (“Red Light Holland” or the “Company”) (CSE:TRIP), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that it has entered into an amended agreement with Eight Capital, pursuant to which Eight Capital has now agreed to buy, on a bought deal basis, 23,000,000 units (“Units”) at a price of $0.44 per Unit (the “Issue Price”), for gross proceeds of $10,120,000 (the “Offering”).
The Company has agreed to grant Eight Capital an over-allotment option to purchase up to an additional 15% of the Units at the Issue Price, exercisable in whole or in part, at any time on or prior to the date that is 30 days following the closing of the Offering. If this option is exercised in full, an additional approximately $1,500,000 will be raised pursuant to the Offering and the aggregate proceeds of the Offering will be approximately $11,600,000.
Posted by AGORACOM
at 8:41 AM on Wednesday, February 3rd, 2021
Red Light Holland Corp. (“Red Light Holland” or the “Company”) (CSE:TRIP), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that it has entered into a letter of engagement with Eight Capital, under which Eight Capital has agreed to purchase, as sole bookrunner and underwriter, 11,600,000 units of the Company (the “Units”), on a “bought deal” basis pursuant to a filing of a short form prospectus, subject to all required regulatory approvals, at a price per Unit of $0.44 (the “Issue Price”) for gross proceeds of $5,060,000 (the “Offering”).
The Company has agreed to grant Eight Capital an over-allotment option to purchase up to an additional 15% of the Units at the Issue Price, exercisable in whole or in part, at any time on or prior to the date that is 30 days following the closing of the Offering. If this option is exercised in full, an additional approximately $750,000 will be raised pursuant to the Offering and the aggregate proceeds of the Offering will be approximately $5,750,000.
Each Unit will be comprised of one common share of the Company (a “Common Share”) and one Common Share purchase warrant (a “Warrant”). Each Warrant shall entitle the holder thereof to purchase one Common Share at an exercise price of $0.70, for a period of 36 months following the closing of the Offering. If the daily volume weighted average trading price of the Common Shares on the Canadian Securities Exchange for any 10 consecutive days equals or exceeds $1.52, the Company may, upon providing written notice to the holders of the Warrants, accelerate the expiry date of the Warrants to the date that is 30 days following the date of such written notice.
Posted by AGORACOM
at 8:29 AM on Wednesday, February 3rd, 2021
Announces Psychedelic Pharmaceutical Production Agreement
Synthesis of pharmaceutical grade psychedelic compounds
Working toward regulatory approval for the commercial production process
XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that XPhyto Laboratories Inc. (“XPhyto Labs”), its wholly owned Alberta subsidiary, has signed an agreement (the “Agreement”) with Applied Pharmaceutical Innovation (“Applied”) for the synthesis of pharmaceutical grade psychedelic compounds and the parallel development of the standard operating procedures necessary to obtain regulatory approval for the respective commercial production process.
The industrial-scale production of standardized active pharmaceutical ingredients is an important part of XPhyto’s psychedelic pharmaceutical program as the Company anticipates a shortage of large-scale supply of certain approved and standardized pharmaceutical grade psychedelics.
Applied is a not-for-profit institution at the University of Alberta created to support translational drug development for industry and innovators. With an interdisciplinary team of over 30 pharmaceutical scientists, clinicians, regulatory, patent, and market experts, Applied provides industry with access to translational science in a framework that supports commercial success. This includes retention of IP and ownership of work product for the funder, focused and efficient project execution, and regulatory compliant operations.
